MiR-297 inhibits tumour progression of liver cancer by targeting PTBP3

Whereas increasing evidences demonstrate that miR-297 contributes to the tumour development and progression, the role of miR-297 and its underlying molecular mechanisms in hepatocellular carcinoma (HCC) was still unclear. Here, we reported that the expression of miR-297 increased significantly in he...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Na, Min, Jiali, Peng, Lin, Huang, Shengjian, Chai, Xiahua, Wang, Susu, Wang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460384/
https://www.ncbi.nlm.nih.gov/pubmed/37633911
http://dx.doi.org/10.1038/s41419-023-06097-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460384/
https://www.ncbi.nlm.nih.gov/pubmed/37633911
http://dx.doi.org/10.1038/s41419-023-06097-0

Ejemplares similares